In addition, SEC14L1 affects innate immune processes by negatively regulating RIG-I-mediated antiviral signaling (Li et al., 2013) and is involved in the immune process of some diseases, such as lymphovascular invasion in breast cancer (Sonbul et al., 2018). This evidence concerns the gene SEC14L1 and breast carcinoma.